Aurobindo Pharma, engaged in manufacture of generic pharmaceuticals and active pharmaceutical ingredients with consolidated net sales of Rs 2,435 crore in 2007-08, has received US FDA approval to manufacture and market risperidone tablets 0.25mg, 0.5mg, 1mg, 2 mg, 3mg and 4mg. This is Aurobindo's 81st ANDA approval from the US FDA.

Risperidone tablets is the generic version of Janssen's Risperdal tablets and is indicated for the treatment of schizophrenia. These tablets have sales of around US$ 1,074 million in the first half of 2008 as per the second quarterly report of Janssen Pharmaceuticals.